Analysts at StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Wednesday. The brokerage set a "hold" rating on the medical instruments supplier's stock.

Pro-Dex Trading Up 1.6 %

Shares of NASDAQ:PDEX opened at $17.79 on Wednesday. The company has a quick ratio of 1.39, a current ratio of 2.73 and a debt-to-equity ratio of 0.41. Pro-Dex has a 12-month low of $12.40 and a 12-month high of $26.50. The firm has a fifty day moving average of $18.19 and a two-hundred day moving average of $17.19. The firm has a market capitalization of $63.69 million, a P/E ratio of 17.11 and a beta of 0.91.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PDEX. Tower Research Capital LLC TRC boosted its position in Pro-Dex by 345.6% in the third quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 2,084 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Pro-Dex during the second quarter worth $168,000. State Street Corp increased its position in shares of Pro-Dex by 5.8% during the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock worth $197,000 after acquiring an additional 650 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock worth $345,000 after purchasing an additional 7,762 shares during the last quarter. Finally, LSV Asset Management boosted its holdings in Pro-Dex by 13.9% during the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock worth $588,000 after purchasing an additional 4,346 shares during the last quarter. Institutional investors own 13.69% of the company's stock.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.

See Also

• Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
• Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
• This Is Why Daktronics Fell 40% In One Day
• Is It Time To Throw In The Towel On Gamestop?
• Why You Should Avoid Carvana Even if it Avoids Bankruptcy
• Are Investors Hearing The End Of Spotify's Downtrend?

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.